AcquisitionOther
Alkermes plc acquired Avadel Pharmaceuticals plc
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Alkermes plc -> Avadel Pharmaceuticals plc · approximately $2.275 billion
Accelerates entry into sleep medicine market and adds LUMRYZ (sodium oxybate) to commercial portfolio, expanding capabilities in neurological disorders treatment.
Open source record (SEC) ↗